Researchers are studying the tumor microenvironment in colorectal cancer to understand therapeutic resistance. Various studies are investigating different aspects, including the role of specific cells and molecules, metabolic pathways, and the interplay between microbiota and immune systems. The findings may reveal potential therapeutic targets for treating colorectal cancer, although the specific mechanisms and targets are still being explored.